Naturally Occurring Mutants Found inHuman Neuroblastomas COOH-Terminal Region of p 73 Which Is Impaired in the Identification of a Transactivation Activity in the Updated Version

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer

  1999cited by this paper
• Mutational analysis of the p73 Gene in human breast cancers

  1999cited by this paper
• Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma

  1999cited by this paper
• p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent

  1999cited by this paper
• Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.

  1998cited by this paper
• Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma.

  1998cited by this paper
• Cloning and functional analysis of human p51, which structurally and functionally resembles p53

  1998cited by this paper
• The p53 tumour suppressor gene

  1998cited by this paper
• p73, a geme related to p53, is not mutated in esophageal carcinomas

  1998cited by this paper
• Wig-1, a new p53-induced gene encoding a zinc finger protein

  1997cited by this paper
• Identification of Essential cis-Acting Regulatory Elements for Transcription of the Rat DAN Gene

  1997cited by this paper
• Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

  1997influential reference
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Tumour-suppressor genes: Killer in search of a motive?

  1997cited by this paper
• p73 is a human p53-related protein that can induce apoptosis

  1997cited by this paper
• p53 in growth control and neoplasia.

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Genomic instability in Ip and human malignancies

  1996cited by this paper
• A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

  1995cited by this paper
• Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.

  1995cited by this paper
• How loops, beta sheets, and alpha helices help us to understand p53.

  1994cited by this paper
• Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

  1994cited by this paper
• p53: a glimpse at the puppet behind the shadow play.

  1994cited by this paper
• Transcriptional activation by p53 correlates with suppression of growth but not transformation.

  1994cited by this paper
• Sequence-specific transcriptional activation is essential for growth suppression by p53.

  1994cited by this paper
• Analysis of the most representative tumour‐derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.

  1994cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• The tumor suppressor p53.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

  1989cited by this paper
• Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif

  1988cited by this paper
• Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.

  1986cited by this paper

• No citing papers are available for this paper.